Innovating Works
IMPORTANT: IMPlementing geriatric assessment for dose Optimization of CDK 4/6-inhibitors in older bReasT cAncer... PHAZE KLINIKI EREVNA FARMAKEFTIKES SYMVOULES ANONYMI ETAIREIA participó en un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 Current evidence from both randomized trials and real-world evidence studies suggests that older breast cancer patients derive clinical bene...
2023-04-24 - 2028-04-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.